Close
4

Quotient Sciences Quotient Sciences

X

Company profile for AB Science

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
AB Science was founded in 2001 by a team of scientists in order to develop new drugs targeting indications with unmet medical needs, in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. In human medicine, our masitinib pipeline is well advanced with several phase 3 studies in oncology and non-oncology diseases and promising data in Amyotrophic Lateral Sclerosis and indolent severe sys...
AB Science was founded in 2001 by a team of scientists in order to develop new drugs targeting indications with unmet medical needs, in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. In human medicine, our masitinib pipeline is well advanced with several phase 3 studies in oncology and non-oncology diseases and promising data in Amyotrophic Lateral Sclerosis and indolent severe systemic mastocytosis. Masitinib is already commercialized in veterinary medicine and we celebrated in 2018 the 10th anniversary of the EMA marketing authorization of our product Masivet.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
AB Science
France Flag
Country
Country
France
Address
Address
3, Avenue George V 75008 PARIS
Telephone
Telephone
+33 (0)1 47 20 00 14
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY